LSTA FY 2011 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-85.6% YoY

Gross Profit

$1M14.0% margin

Operating Income

-$34M-338.4% margin

Net Income

-$47M-469.0% margin

EPS (Diluted)

$-810.00

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$155M

Total Liabilities

$75M

Stockholders' Equity

$62M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$70M	-85.6%
Gross Profit	$1M	$20M	-93.0%
Operating Income	-$34M	-$19M	-80.1%
Net Income	-$47M	-$23M	-102.2%